BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10223341)

  • 1. Yeast cells allow high-level expression and formation of polyomavirus-like particles.
    Sasnauskas K; Buzaite O; Vogel F; Jandrig B; Razanskas R; Staniulis J; Scherneck S; Krüger DH; Ulrich R
    Biol Chem; 1999 Mar; 380(3):381-6. PubMed ID: 10223341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutation in calcium-binding domain of mouse polyomavirus VP1 protein does not prevent virus-like particle formation, but changes VP1 interactions with Saccharomyces cerevisiae cell structures.
    Adamec T; Palková Z; Velková K; Stokrová J; Forstová J
    FEMS Yeast Res; 2005 Feb; 5(4-5):331-40. PubMed ID: 15691738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.
    Gedvilaite A; Aleksaite E; Staniulis J; Ulrich R; Sasnauskas K
    Arch Virol; 2006 Sep; 151(9):1811-25. PubMed ID: 16575481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
    Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
    Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
    Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
    Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.
    Voronkova T; Kazaks A; Ose V; Ozel M; Scherneck S; Pumpens P; Ulrich R
    Virus Genes; 2007 Jun; 34(3):303-14. PubMed ID: 16927120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunodominant, cross-reactive B-cell epitope region is located at the C-terminal part of the hamster polyomavirus major capsid protein VP1.
    Siray H; Frömmel C; Voronkova T; Hahn S; Arnold W; Schneider-Mergener J; Scherneck S; Ulrich R
    Viral Immunol; 2000; 13(4):533-45. PubMed ID: 11192300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsid protein-encoding genes of hamster polyomavirus and properties of the viral capsid.
    Siray H; Ozel M; Jandrig B; Voronkova T; Jia W; Zocher R; Arnold W; Scherneck S; Krüger DH; Ulrich R
    Virus Genes; 1999; 18(1):39-47. PubMed ID: 10334036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
    Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
    Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
    Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the carboxyl-terminal region of the SV40 major capsid protein VP1.
    Yokoyama N; Kawano MA; Tsukamoto H; Enomoto T; Inoue T; Takahashi RU; Nakanishi A; Imai T; Wada T; Handa H
    J Biochem; 2007 Feb; 141(2):279-86. PubMed ID: 17283011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and physical characterization of parvovirus minute virus of mice virus-like particles.
    Hernando E; Llamas-Saiz AL; Foces-Foces C; McKenna R; Portman I; Agbandje-McKenna M; Almendral JM
    Virology; 2000 Feb; 267(2):299-309. PubMed ID: 10662625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of molecular chaperone requirement for the biosynthesis of hamster polyomavirus VP1 protein in Saccharomyces cerevisiae.
    Valaviciute M; Norkiene M; Goda K; Slibinskas R; Gedvilaite A
    Arch Virol; 2016 Jul; 161(7):1807-19. PubMed ID: 27038828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli.
    Braun H; Boller K; Löwer J; Bertling WM; Zimmer A
    Biotechnol Appl Biochem; 1999 Feb; 29 ( Pt 1)():31-43. PubMed ID: 9889083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.